Company: SVREW
Filing Date: 2025-01-31
Form Type: 424B5
Source: 0001213900-25-008656
Chunk: 18

Company: SaverOne 2014 Ltd.
Filing Date: 2025-01-31
Form: 424B5
Chunk 18
---
-four (24) months thereafter. See “Private Placement Transaction.” |

<div align='center'>S-10</div>

| Placement Agent |     | We have                                                                                                                           
 engaged H.C. Wainwright as our exclusive placement agent in connection with this offering. H.C. Wainwright is not required to     
 buy or sell any specific number or dollar amount of the securities offered hereby, but it will use its reasonable best efforts to 
 solicit offers to purchase the securities offered by this prospectus. See “Plan of Distribution” on page S-20 of                  
 this prospectus supplement.                                                                                                       |
| Depositary      |     | The Bank of New York Mellon                                                                                                       |

The above table is based on 479,723,076 ordinary shares outstanding as of January 30, 2025 and excludes as of such date the following:

| ● | 1,763,854                                                                                                                                          
 ordinary shares issuable upon exercise of options outstanding under the 2015 Plan, at a weighted average exercise price of NIS 5.50 (approximately 
 $1.54) per share;                                                                                                                                  |

| ● | 450,000                                                 
 restricted share units outstanding under the 2015 Plan; |

| ● | 3,336,146                                                         
 ordinary shares reserved for future issuance under our 2015 Plan; |

| ● | 16,383,410                                                                                                                             
 ordinary shares issuable upon the exercise of warrants sold in our initial public offering, or IPO, in the United States in June 2022; 
 and                                                                                                                                    |

| ● | 787,550 ordinary shares                                                                                                                   
 issuable upon the exercise of warrants granted to the underwriters in connection with our IPO.                                            |
| ● | 390,857,940                                                                                                                               
 ordinary shares represented by 4,342,866 ADSs issuable upon the exercise of the Private Placement Warrants to be issued in the concurrent 
 private placement at an exercise price of $0.80 per ADS; and                                                                              |
| ● | 13,680,000                                                                                                                                
 ordinary shares represented by 152,000 ADSs issuable upon the exercise of placement agent warrants to be issued as compensation to the    
 placement agent (or its designee) in connection with this offering at an exercise price of $0.875 per ADS.                                |

Except as otherwise indicated, all information in this prospectus supplement assumes no exercise of the outstanding options, or warrants described above.

<div align='center'>S-11

RISK FACTORS